Website News and Research

RSS

Credicorp files 2009 Annual Report on Form 20-F

Credicorp filed an Annual Report on Form 20-F for the year ended December 31, 2009 with the Securities and Exchange Commission ("SEC"). The 2009 Form 20-F includes audited consolidated financial statements of Credicorp and its subsidiaries as of December 31, 2008 and 2009 and for the years ended December 31, 2007, 2008 and 2009 under IFRS.

19 Jun 2010

TMLTExposed.org files suit against Texas Medical Liability Trust

On June 18, 2010, the Registrant of the website www.TMLTExposed.org filed suit against Texas Medical Liability Trust in the 68th Judicial District Court of Dallas County, Texas requesting a declaratory judgment that the contents of the website are protected speech under the First Amendment to the United States Constitution and Article I, Section 8 of the Texas Constitution.

19 Jun 2010

Hospitals work to reduce wait times, readmission rates

The Baltimore Sun writes about hospitals working to reduce emergency room wait times and then advertising the results. "St. Joseph Medical Center [in Towson, Md.] posts the anticipated wait time on its website. Harbor Hospital in South Baltimore has put up billboards and handed out brochures door-to-door to tell residents about its 'quick' emergency room experience.

19 Jun 2010

Inspire's TIGER-1 Phase 3 clinical trial data with denufosol for CF presented at 33rd ECFS

Inspire Pharmaceuticals, Inc. announced today that data is being presented on denufosol tetrasodium, an investigational therapy for cystic fibrosis (CF), during an oral presentation and poster presentations at the 33rd Annual European Cystic Fibrosis Society (ECFS) Conference June 16 - 19, 2010 in Valencia, Spain.

18 Jun 2010

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

Amylin Pharmaceuticals, Inc. today announced that the Company will present data for its FDA-approved diabetes drugs, BYETTA (exenatide) injection and SYMLIN (pramlintide acetate) injection, and its investigational diabetes drug candidate BYDUREON (exenatide extended-release for injectable suspension) at the American Diabetes Association's 70th Annual Scientific Sessions being held in Orlando, FL from June 25 to June 29.

18 Jun 2010

Fraudulent Tamiflu sold over Internet, FDA warns

The U.S. Food and Drug Administration today warned consumers about a potentially harmful product represented as "Generic Tamiflu" sold over the Internet. FDA tests revealed that the fraudulent product does not contain Tamiflu's active ingredient, oseltamivir, but cloxacillin, an ingredient in the same class of antibiotics as penicillin.

18 Jun 2010

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has notified the company of the tentative scheduling of a Psychopharmacologic Drugs Advisory Committee meeting on September 16, 2010, for the review of the company's supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) for opioid dependence.

18 Jun 2010

Democrats scale back 'doc fix' in pursuit of votes to pass jobs bill, Medicaid provision may be dropped

A bill that would, among other things, extend some unemployment benefits and provide a temporary fix for Medicare physician payment rates languished in the Senate Wednesday as a procedural vote to end debate on the bill failed, 52 to 45, The Wall Street Journal reports. Eleven Democrats broke with the party to vote no.

18 Jun 2010

Research identifies early biomarker for insulin resistance, glucose intolerance in nondiabetic population

Metabolon, Inc., the leader in metabolomics-based biomarker discovery and analysis, today announced the publication of research that identified a novel, early biomarker for insulin resistance and glucose intolerance in a nondiabetic population.

17 Jun 2010

McKesson reaffirms earnings guidance for fiscal 2011

McKesson Corporation today reaffirmed its earnings guidance for the fiscal year ending March 31, 2011 and the underlying key assumptions provided in its press release of May 3, 2010. As previously stated, McKesson expects to earn between $4.72 and $4.92 per diluted share for the fiscal year ending March 31, 2011.

17 Jun 2010

Pharmacyclics increases number of shares to be sold in registered direct offering by 1.9M

Pharmacyclics, Inc. today announced that it has increased the number of shares to be sold in the registered direct offering previously announced on June 15, 2010 by approximately 1.9 million shares, for a total offering of approximately 8 million shares. The increase in the number of shares was due to additional demand from institutional investors who were previously participating in the registered direct offering.

17 Jun 2010

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Chelsea Therapeutics International, Ltd. announced that data from its pivotal studies of Northera™ (droxidopa) in symptomatic neurogenic orthostatic hypotension was presented during a poster session and featured in a symposium highlighting the role of norepinephrine (NE) deficiency in Parkinson's disease at the 14th International Congress on Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina.

17 Jun 2010

Pharmacyclics announces $40M registered direct offering of common stock

Pharmacyclics, Inc. today announced that it has entered into stock purchase agreements with various institutional investors for the sale of approximately 6,150,000 shares of its common stock in a registered direct offering at $6.51 per share, the closing price on June 15, 2010.

17 Jun 2010

Healthcare clinicians' disruptive behaviors negatively affect patient care: Data

Disruptive behavior was reported in 177 events submitted to the Pennsylvania Patient Safety Authority from May 2007 to October 2009. In many of the events patient care was compromised, according to data released today by the Pennsylvania Patient Safety Authority and published in the June Supplementary Pennsylvania Patient Safety Advisory.

17 Jun 2010

FDA unveils safety reports on recently approved drugs, biologics

The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.

16 Jun 2010

New public service advertisements to spread preventive medical testing awareness

Men are 24 percent less likely than women to have visited the doctor within the past year, according to new data released today by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality. In addition, men are about 30 percent more likely than women to be hospitalized for preventable conditions such as congestive heart failure and complications from diabetes, according to new AHRQ data.

16 Jun 2010

Oakwood Healthcare selects RL Solutions as partner for infection control and prevention

RL Solutions, makers of innovative and easy-to-use healthcare quality and safety software, today announced that Oakwood Healthcare has selected RL Solutions as its partner for infection control and prevention. A long-time client, Oakwood is currently using RL Solutions products for risk management, patient feedback and medical claims management.

15 Jun 2010

CRH Medical's marketing program provides new patient inquiries to physicians

CRH Medical Corporation announced today that its innovative marketing program is providing significant new patient inquiries to physicians listed on the Company's website who have been trained in the use of the Company's proprietary technology and methods known as the CRH O'Regan System.

15 Jun 2010

APR launches new Corporate Website, changes Business Model

APR announces today the launch of its new Corporate Website reflecting a clear strategic change in the APR Business Model and competitive positioning in order to better compete in the very rapidly changing Healthcare market. The company repositioning is also reflected in its revised logo.

15 Jun 2010

Talaris Institute launches new online service for parents of young children

Talaris Institute, a nonprofit organization in Seattle, Washington, is proud to announce the launch of the new online service for parents of children birth to five – www.ParentingCounts.org. After nearly a decade of analyzing research and millions of dollars spent developing factual and practical content for parents, Talaris Institute introduced the Parenting Counts Center in November 2009 as a source of research-based information about child development with an exclusive birth-to-five developmental timeline.

15 Jun 2010

Website News and Research

Credicorp files 2009 Annual Report on Form 20-F

TMLTExposed.org files suit against Texas Medical Liability Trust

Hospitals work to reduce wait times, readmission rates

Inspire's TIGER-1 Phase 3 clinical trial data with denufosol for CF presented at 33rd ECFS

Data on BYETTA and SYMLIN injections, BYDUREON drug candidate to be presented at ADA 2010

Fraudulent Tamiflu sold over Internet, FDA warns

Alkermes receives tentative schedule notification for FDA advisory committee meeting on VIVITROL sNDA

Democrats scale back 'doc fix' in pursuit of votes to pass jobs bill, Medicaid provision may be dropped

Research identifies early biomarker for insulin resistance, glucose intolerance in nondiabetic population

McKesson reaffirms earnings guidance for fiscal 2011

Pharmacyclics increases number of shares to be sold in registered direct offering by 1.9M

Chelsea presents Northera study data at International Congress on Parkinson's Disease and Movement Disorders

Pharmacyclics announces $40M registered direct offering of common stock

Healthcare clinicians' disruptive behaviors negatively affect patient care: Data

FDA unveils safety reports on recently approved drugs, biologics

New public service advertisements to spread preventive medical testing awareness

Oakwood Healthcare selects RL Solutions as partner for infection control and prevention

CRH Medical's marketing program provides new patient inquiries to physicians

APR launches new Corporate Website, changes Business Model

Talaris Institute launches new online service for parents of young children

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News